Dr. Shanu Modi led DESTINY-Breast04, a groundbreaking study that resulted in FDA approval of a promising treatment that can improve survival for nearly 50% of all patients with metastatic breast cancer today. This Conquer Cancer grant recipient talks about the importance of patient participation in clinical trials, the necessity of donor-funded research, and the bright future of breast cancer care.
